
### [MONDO:0003832](http://purl.obolibrary.org/obo/MONDO_0003832)
**Label:** complement deficiency

**Subclasses:** [MONDO:0013343](http://purl.obolibrary.org/obo/MONDO_0013343) (C1Q deficiency), [MONDO:0012295](http://purl.obolibrary.org/obo/MONDO_0012295) (complement component 5 deficiency), [MONDO:0013421](http://purl.obolibrary.org/obo/MONDO_0013421) (type II complement component 8 deficiency), [MONDO:0013422](http://purl.obolibrary.org/obo/MONDO_0013422) (type i complement component 8 deficiency), [MONDO:0012594](http://purl.obolibrary.org/obo/MONDO_0012594) (complement factor I deficiency), [MONDO:0009005](http://purl.obolibrary.org/obo/MONDO_0009005) (complement component C1R/C1S deficiency), [MONDO:0009006](http://purl.obolibrary.org/obo/MONDO_0009006) (complement component 2 deficiency), [MONDO:0000015](http://purl.obolibrary.org/obo/MONDO_0000015) (complement component deficiency), [MONDO:0012908](http://purl.obolibrary.org/obo/MONDO_0012908) (complement component 6 deficiency), [MONDO:0013417](http://purl.obolibrary.org/obo/MONDO_0013417) (complement component 3 deficiency), [MONDO:0012412](http://purl.obolibrary.org/obo/MONDO_0012412) (complement component 7 deficiency), [MONDO:0007361](http://purl.obolibrary.org/obo/MONDO_0007361) (C1 inhibitor deficiency), [MONDO:0013419](http://purl.obolibrary.org/obo/MONDO_0013419) (complement component C1S deficiency), [MONDO:0013720](http://purl.obolibrary.org/obo/MONDO_0013720) (complement component 4b deficiency), [MONDO:0013445](http://purl.obolibrary.org/obo/MONDO_0013445) (complement component 9 deficiency), [MONDO:0013721](http://purl.obolibrary.org/obo/MONDO_0013721) (complement component 4a deficiency), 

**Mapped go classes:** [GO:0019835](http://purl.obolibrary.org/obo/GO_0019835) (cytolysis), [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle), [GO:0030193](http://purl.obolibrary.org/obo/GO_0030193) (regulation of blood coagulation), [GO:0006883](http://purl.obolibrary.org/obo/GO_0006883) (cellular sodium ion homeostasis), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0044279](http://purl.obolibrary.org/obo/GO_0044279) (other organism membrane), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0048639](http://purl.obolibrary.org/obo/GO_0048639) (positive regulation of developmental growth), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0006957](http://purl.obolibrary.org/obo/GO_0006957) (complement activation, alternative pathway), [GO:0031715](http://purl.obolibrary.org/obo/GO_0031715) (C5L2 anaphylatoxin chemotactic receptor binding), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001867](http://purl.obolibrary.org/obo/GO_0001867) (complement activation, lectin pathway), [GO:0001869](http://purl.obolibrary.org/obo/GO_0001869) (negative regulation of complement activation, lectin pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0070207](http://purl.obolibrary.org/obo/GO_0070207) (protein homotrimerization), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0001906](http://purl.obolibrary.org/obo/GO_0001906) (cell killing), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001798](http://purl.obolibrary.org/obo/GO_0001798) (positive regulation of type IIa hypersensitivity), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010866](http://purl.obolibrary.org/obo/GO_0010866) (regulation of triglyceride biosynthetic process), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0090197](http://purl.obolibrary.org/obo/GO_0090197) (positive regulation of chemokine secretion), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0044216](http://purl.obolibrary.org/obo/GO_0044216) (other organism cell), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0044218](http://purl.obolibrary.org/obo/GO_0044218) (other organism cell membrane), [GO:0001970](http://purl.obolibrary.org/obo/GO_0001970) (positive regulation of activation of membrane attack complex), [GO:0045745](http://purl.obolibrary.org/obo/GO_0045745) (positive regulation of G-protein coupled receptor protein signaling pathway), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0001849](http://purl.obolibrary.org/obo/GO_0001849) (complement component C1q binding), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0045916](http://purl.obolibrary.org/obo/GO_0045916) (negative regulation of complement activation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0045917](http://purl.obolibrary.org/obo/GO_0045917) (positive regulation of complement activation), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0061304](http://purl.obolibrary.org/obo/GO_0061304) (retinal blood vessel morphogenesis), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0005579](http://purl.obolibrary.org/obo/GO_0005579) (membrane attack complex), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:2000427](http://purl.obolibrary.org/obo/GO_2000427) (positive regulation of apoptotic cell clearance), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0048037](http://purl.obolibrary.org/obo/GO_0048037) (cofactor binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0010760](http://purl.obolibrary.org/obo/GO_0010760) (negative regulation of macrophage chemotaxis), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.00%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.00%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.36%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005224](http://purl.obolibrary.org/obo/GO_0005224) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005218](http://purl.obolibrary.org/obo/GO_0005218) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005211](http://purl.obolibrary.org/obo/GO_0005211) (obsolete plasma glycoprotein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005209](http://purl.obolibrary.org/obo/GO_0005209) (obsolete plasma protein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005208](http://purl.obolibrary.org/obo/GO_0005208) (obsolete amyloid protein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005207](http://purl.obolibrary.org/obo/GO_0005207) (obsolete extracellular matrix glycoprotein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005206](http://purl.obolibrary.org/obo/GO_0005206) (obsolete heparin sulfate proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005205](http://purl.obolibrary.org/obo/GO_0005205) (obsolete chondroitin sulfate/dermatan sulfate proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005204](http://purl.obolibrary.org/obo/GO_0005204) (obsolete chondroitin sulfate proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005203](http://purl.obolibrary.org/obo/GO_0005203) (obsolete proteoglycan) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.36%


